These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29203377)

  • 21. Genetic model of transformation and neoplastic progression in laryngeal epithelium.
    Marcos CÁ; Alonso-Guervós M; Prado NR; Gimeno TS; Iglesias FD; Hermsen M; Llorente JL
    Head Neck; 2011 Feb; 33(2):216-24. PubMed ID: 20629083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Precancerous lesions of the buccal mucosa].
    Ben Slama L
    Rev Stomatol Chir Maxillofac; 2001 Apr; 102(2):77-108. PubMed ID: 11446145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stomach - Genetic and epigenetic alterations of preneoplastic and neoplastic lesions.
    David S; Meltzer SJ
    Cancer Biomark; 2010; 9(1-6):493-507. PubMed ID: 22112492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.
    Hsue SS; Wang WC; Chen CH; Lin CC; Chen YK; Lin LM
    J Oral Pathol Med; 2007 Jan; 36(1):25-9. PubMed ID: 17181738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A classification of melanocytic dysplasias and malignant melanomas.
    Reed RJ
    Am J Dermatopathol; 1984; 6 Suppl():195-206. PubMed ID: 6528920
    [No Abstract]   [Full Text] [Related]  

  • 26. Early Barrett's carcinoma of the esophagus.
    Hölscher AH; Vallböhmer D; Bollschweiler E
    Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920
    [No Abstract]   [Full Text] [Related]  

  • 27. Potentially Malignant Oral Disorders and Cancer Transformation.
    Ganesh D; Sreenivasan P; Öhman J; Wallström M; Braz-Silva PH; Giglio D; Kjeller G; Hasséus B
    Anticancer Res; 2018 Jun; 38(6):3223-3229. PubMed ID: 29848669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Case for a Pre-Cancer Genome Atlas (PCGA).
    Campbell JD; Mazzilli SA; Reid ME; Dhillon SS; Platero S; Beane J; Spira AE
    Cancer Prev Res (Phila); 2016 Feb; 9(2):119-24. PubMed ID: 26839336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elucidating drivers of oral epithelial dysplasia formation and malignant transformation to cancer using RNAseq.
    Conway C; Graham JL; Chengot P; Daly C; Chalkley R; Ross L; Droop A; Rabbitts P; Stead LF
    Oncotarget; 2015 Nov; 6(37):40186-201. PubMed ID: 26515596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Precursor lesions: epidemiology--is there enough evidence?].
    Hofstädter F
    Pathologe; 2011 Nov; 32 Suppl 2():185-7. PubMed ID: 21915660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precancerous colorectal lesions (Review).
    Conteduca V; Sansonno D; Russi S; Dammacco F
    Int J Oncol; 2013 Oct; 43(4):973-84. PubMed ID: 23900573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preneoplastic and preinvasive lesions of the esophagus and stomach.
    Lai M
    Pathologe; 2011 Nov; 32 Suppl 2():1-2, 195-6. PubMed ID: 22033681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Precancerous lesions in the kidney.
    Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
    Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders.
    Sperandio M; Brown AL; Lock C; Morgan PR; Coupland VH; Madden PB; Warnakulasuriya S; Møller H; Odell EW
    Cancer Prev Res (Phila); 2013 Aug; 6(8):822-31. PubMed ID: 23761273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serrated polyps and colorectal cancer: new pathway to malignancy.
    Noffsinger AE
    Annu Rev Pathol; 2009; 4():343-64. PubMed ID: 19400693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-tumour clones, periodic selection and clonal interference in the origin and progression of gastrointestinal cancer: potential for biomarker development.
    Baker AM; Graham TA; Wright NA
    J Pathol; 2013 Mar; 229(4):502-14. PubMed ID: 23288692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular genetics of premalignant oral lesions.
    Mithani SK; Mydlarz WK; Grumbine FL; Smith IM; Califano JA
    Oral Dis; 2007 Mar; 13(2):126-33. PubMed ID: 17305612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fields and field cancerization: the preneoplastic origins of cancer: asymptomatic hyperplastic fields are precursors of neoplasia, and their progression to tumors can be tracked by saturation density in culture.
    Rubin H
    Bioessays; 2011 Mar; 33(3):224-31. PubMed ID: 21254148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance of pre-malignant disease of the pancreatico-biliary system.
    Friess H; Holzinger F; Liao Q; Büchler MW
    Best Pract Res Clin Gastroenterol; 2001 Apr; 15(2):285-300. PubMed ID: 11355916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral cancer: diagnostic options as an aid to histology in order to predict patients at high risk for malignant transformation.
    Akrish S; Buchner A; Dayan D
    Refuat Hapeh Vehashinayim (1993); 2004 Oct; 21(4):6-15, 93. PubMed ID: 15672638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.